(ETC)Bondex 3mg/3ml PFS - Ibandronate

SKU: 155-1
  • - Active ingredient
    Ibandronate sodium monohydrate 3.375 mg/3 mL (as Ibandronate 3 mg)


    - Indication
    Treatment of Postmenopausal Osteoporosis 


    - Dosage & Administration
    3 mg every 3 months administered intravenously over a period of 15 to 30 seconds.

     

    Instruct patients to take supplemental calcium and vitamin D.

     

    If the dose is missed, administer as soon as it can be re-scheduled. Thereafter, BONDEX Injection should be scheduled every 3 months from the date of the last injection.

KOTRA SouthAsia

Address: 3rd Floor, Asset 307, Worldmark3, 

Aerocity, New Delhi

Tel: +91-11-4230-6300

Email: kotra@onlinekorea.org

New Delhi office

Mumbai office

Chennai office

Bengaluru office

Kolkata office

Ahmedabad office

Karachi office

Dhaka office

Colombo office

9 Branches detail

Quick Links:

All Products
Upcoming Event
News

FAQs
About KOTRA SouthAsia

©2020 Copyright by KOTRA